Table 2 Outcomes of risk-reducing salpingo-oophorectomy.

From: Impact of the coverage of risk-reducing salpingo-oophorectomy by the national insurance system for women with BRCA pathogenic variants in Japan

 

Period A

Period B

p-value

Number

45

89

 

Study period

36 months

24 months

 

Number per month

1.25

3.71

 

Unaffected carriers

Every 6 months

Every 4 months

0.74

Concurrent RRMa

4 (8.9%)

21 (23.6%)

0.07

Concurrent surgery for BCb

0

21 (23.6%)

 < 0.01

Concurrent RRM and surgery for BC

0

7 (7.9%)

0.094

Concurrent hysterectomy (except previous hysterectomy)

29 (66%)

7 (7.9%)

 < 0.01

  1. aRisk-reducing mastectomy.
  2. bBreast cancer.